| Application no. and date | 15750744.3 (espacenet) (Federated) (European Patent Register), 20150814 | | Patent/reg. no. and date | DK/EP 3180363, 20190925 | | Publication date | 20170621 | | Priority no. and date | US 201462038196 P, 20140815 | | EP pub. no. and date |
EP 3180363 20170621 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | P69972DK01 | | Inventor | LO, Kin-Ming, 6 Carol Lane
Lexington, Massachusetts 02420, US,
ZIZLSPERGER, Nora, 164 Linwood Avenue
Newton, Massachusetts 02460, US,
SIRCAR, Aroop, 13 Kenmar Drive
Unit 31
Billerica,
MA 01821, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , C07K 14/705 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C07K 16/32 (2006.01) , C07K 16/46 (2006.01) , C12N 9/16 (2006.01) | | Title | SIRP-ALPHA-IMMUNOGLOBULIN FUSIONSPROTEINER | | Int. application no. | EP2015068798 | | Int. publication no. | WO2016024021 | | Related patent (certificate) | | | Status | Ændret EP patent ikke valid i DK | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
